Ildefonso Hervás

538 total citations
6 papers, 453 citations indexed

About

Ildefonso Hervás is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Ildefonso Hervás has authored 6 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 2 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Ildefonso Hervás's work include Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Treatment of Major Depression (2 papers). Ildefonso Hervás is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Treatment of Major Depression (2 papers). Ildefonso Hervás collaborates with scholars based in Spain and Brazil. Ildefonso Hervás's co-authors include Francesc Artigas, Luz Romero, Claudio M. Queiroz, Albert Adell, Andrés G. Fernández, José Palacios, N. Bel, Marisabel Mourelle, Pau Celada and Raúl Martín‐Ruiz and has published in prestigious journals such as British Journal of Pharmacology, Neuropsychopharmacology and European Journal of Pharmacology.

In The Last Decade

Ildefonso Hervás

6 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ildefonso Hervás Spain 6 370 193 128 69 56 6 453
L J Boothman United Kingdom 6 441 1.2× 143 0.7× 110 0.9× 86 1.2× 55 1.0× 9 570
John J. Rutter United States 8 424 1.1× 171 0.9× 121 0.9× 61 0.9× 42 0.8× 10 499
Taiichiro Imanishi Japan 11 208 0.6× 168 0.9× 129 1.0× 68 1.0× 40 0.7× 17 422
Claire Roberts United Kingdom 13 384 1.0× 270 1.4× 69 0.5× 75 1.1× 49 0.9× 15 515
Benjamin Di Cara France 11 262 0.7× 181 0.9× 69 0.5× 97 1.4× 80 1.4× 12 421
Martin R. Guscott United Kingdom 7 295 0.8× 178 0.9× 59 0.5× 77 1.1× 46 0.8× 7 418
Sylvie Veiga France 11 492 1.3× 277 1.4× 75 0.6× 67 1.0× 91 1.6× 16 647
Fany Panayi France 11 290 0.8× 229 1.2× 90 0.7× 86 1.2× 62 1.1× 16 533
Daniel Dlaboga Poland 11 186 0.5× 278 1.4× 154 1.2× 38 0.6× 29 0.5× 16 462
Rachel F. Genn United Kingdom 11 315 0.9× 233 1.2× 125 1.0× 111 1.6× 82 1.5× 12 514

Countries citing papers authored by Ildefonso Hervás

Since Specialization
Citations

This map shows the geographic impact of Ildefonso Hervás's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildefonso Hervás with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildefonso Hervás more than expected).

Fields of papers citing papers by Ildefonso Hervás

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ildefonso Hervás. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildefonso Hervás. The network helps show where Ildefonso Hervás may publish in the future.

Co-authorship network of co-authors of Ildefonso Hervás

This figure shows the co-authorship network connecting the top 25 collaborators of Ildefonso Hervás. A scholar is included among the top collaborators of Ildefonso Hervás based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ildefonso Hervás. Ildefonso Hervás is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Romero, Luz, Pau Celada, Raúl Martín‐Ruiz, et al.. (2002). Modulation of Serotonergic Function in Rat Brain by VN2222, a Serotonin Reuptake Inhibitor and 5-HT1A Receptor Agonist. Neuropsychopharmacology. 28(3). 445–456. 27 indexed citations
2.
Hervás, Ildefonso. (2001). Desensitization of 5-HT1A Autoreceptors by a Low Chronic Fluoxetine Dose Effect of the Concurrent Administration of WAY-100635. Neuropsychopharmacology. 24(1). 11–20. 92 indexed citations
3.
Hervás, Ildefonso, Claudio M. Queiroz, Albert Adell, & Francesc Artigas. (2000). Role of uptake inhibition and autoreceptor activation in the control of 5‐HT release in the frontal cortex and dorsal hippocampus of the rat. British Journal of Pharmacology. 130(1). 160–166. 87 indexed citations
4.
Hervás, Ildefonso, N. Bel, Andrés G. Fernández, José Palacios, & Francesc Artigas. (1998). In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(3). 315–322. 42 indexed citations
5.
Hervás, Ildefonso & Francesc Artigas. (1998). Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. European Journal of Pharmacology. 358(1). 9–18. 104 indexed citations
6.
Romero, Luz, Ildefonso Hervás, & Francesc Artigas. (1996). The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters. 219(2). 123–126. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026